[Treatment of patients with acute coronary syndrome in the United States with glycoprotein IIb/IIIa inhibitors. Data provided by the PURSUIT study].
Galvani
M
M
Unità di Terapia Intensiva Coronarica, Ospedale G.B. Morgagni, Fondazione Cardiologica Sacco, Forlì.
D000208:Acute Disease; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D000077542:Eptifibatide; D005260:Female; D006801:Humans; D008297:Male; D010455:Peptides / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013577:Syndrome; D014481:United States
D010455:Peptides; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077542:Eptifibatide
Trattamento dei pazienti con sindrome coronarica acuta negli Stati Uniti con inibitori della glicoproteina IIb/IIIa. Informazioni fornite dallo studio PURSUIT.